Glenmark Pharmaceuticals consolidated net profit rises 15.88% in the December 2025 quarter
(31 Jan 2026)

Back
Net profit of Glenmark Pharmaceuticals rose 15.88% to Rs 403.21 crore in the quarter ended December 2025 as against Rs 347.96 crore during the previous quarter ended December 2024. Sales rose 17.75% to Rs 3888.00 crore in the quarter ended December 2025 as against Rs 3301.90 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales3888.003301.90 18
OPM %22.3718.18 -
PBDT872.79579.06 51
PBT718.34456.33 57
NP403.21347.96 16

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew